Table 8 Incremental Cost Effectiveness Ratio (ICER) in scenario-based sensitivity analysis
Variables | iCaPPS© | Conventional Care | ||||
|---|---|---|---|---|---|---|
Best case | Base case | Worst case | Best case | Base case | Worst case | |
Therapy cost (MYR) | 757.86 | 790.34 | 1308.03 | 440.48 | 527.22 | 546.55 |
QALY gained | 0.55 | 0.55 | 0.55 | 0.32 | 0.32 | 0.32 |
Cost per QALY gained | 1377.92 | 1436.98 | 2378.24 | 1376.50 | 1024.96 | 1707.97 |
Incremental Cost (MYR) | 317.38 | 263.12 | 761.48 | – | – | – |
Incremental effectiveness | 0.23 | 0.23 | 0.23 | – | – | – |
ICER (RM per QALY) (2012 prices) | 1379.91 | 1144.00 | 3310.78 | – | – | – |